Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
株式のランク #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
株価
$0.14942078
最終同期: 2025-05-15
時価総額
$3.86M
変化(1日)
0.10%
変化(1年)
0.00%
DE
取引 Medigene AG (MDG1)

カテゴリー

Medigene AG(MDG1)の利益
Jun 2024 時点の利益 TTM: $-16.77M
Medigene AG の最新の財務報告によると、同社の現在の利益は $-16.77M です。2022 年には $-10.06M の利益を上げ、これは 2021 年の利益 $-11.69M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Medigene AG の利益の推移(2004 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $-16.77M -8.57%
2023 $-18.34M 82.41%
2022 $-10.06M -14.01%
2021 $-11.69M -66.20%
2020 $-34.59M 54.79%
2019 $-22.35M -10.30%
2018 $-24.91M 60.47%
2017 $-15.53M 51.81%
2016 $-10.23M -33.71%
2015 $-15.43M 115.69%
2014 $-7.15M -49.32%
2013 $-14.11M -27.68%
2012 $-19.52M -2.57%
2011 $-20.03M -44.87%
2010 $-36.34M 15.53%
2009 $-31.45M -31.91%
2008 $-46.19M 0.82%
2007 $-45.82M 357.81%
2006 $-10.01M -29.67%
2005 $-14.23M -17.13%
2004 $-17.17M 0.00%
同業他社の利益
企業 利益 利益の差
$5.27B -31,555.72%
US
$1.95B -11,732.28%
NL
- -
CH
- -
KR
$3.01B -18,023.94%
BE